CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $207 | -99.9% | 147,857 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $228,000 | -29.8% | 147,857 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $325,000 | -11.4% | 147,857 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $367,000 | -67.6% | 147,857 | -21.5% | 0.00% | -71.4% |
| Q4 2021 | $1,132,000 | -2.0% | 188,357 | +8.7% | 0.01% | -12.5% |
| Q3 2021 | $1,155,000 | +3.5% | 173,357 | +3.3% | 0.01% | -11.1% |
| Q2 2021 | $1,116,000 | -23.7% | 167,857 | +6.3% | 0.01% | -30.8% |
| Q1 2021 | $1,462,000 | -40.2% | 157,857 | +16.2% | 0.01% | -58.1% |
| Q4 2020 | $2,444,000 | +26.8% | 135,850 | 0.0% | 0.03% | +6.9% |
| Q3 2020 | $1,928,000 | +183.5% | 135,850 | +0.1% | 0.03% | +141.7% |
| Q2 2020 | $680,000 | – | 135,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |